Literature DB >> 20425295

Peripheral vasculopathy associated with psychostimulant treatment in children with attention-deficit/hyperactivity disorder.

Zheya Jenny Yu1, Caroline Parker-Kotler, Kathleen Tran, Ronald A Weller, Elizabeth B Weller.   

Abstract

Psychostimulants (methylphenidate and amphetamine salt) are the pharmacologic treatment of choice for children with attention-deficit/hyperactivity disorder. However, psychostimulants have been linked to a variety of vascular problems, including peripheral vasculopathy. This article describes four boys with attention-deficit/hyperactivity disorder who developed vasculopathy during treatment with psychostimulants.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20425295     DOI： 10.1007/s11920-010-0093-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  7 in total

1.  Peripheral vasculopathy and nephropathy in association with phentermine.

Authors:  H J Jefferson; D R Jayne
Journal:  Nephrol Dial Transplant       Date:  1999-07       Impact factor: 5.992

2.  Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy')

Authors:  C Bingham; M Beaman; A J Nicholls; P P Anthony
Journal:  Nephrol Dial Transplant       Date:  1998-10       Impact factor: 5.992

3.  Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

Authors:  James Guevara; Paula Lozano; Thomas Wickizer; Loren Mell; Harlan Gephart
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

4.  Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs.

Authors:  D L Thai; L N Yurasits; G R Rudolph; J M Perel
Journal:  Drug Metab Dispos       Date:  1999-06       Impact factor: 3.922

5.  A 22-year-old woman with lower limb arteriopathy. Buerger's disease, or methamphetamine- or cannabis-induced arteritis?

Authors:  Boris Leithäuser; Alexander C Langheinrich; Wigbert S Rau; Harald Tillmanns; F Reinhard Matthias
Journal:  Heart Vessels       Date:  2005-02       Impact factor: 2.037

6.  Possible association of ischemic stroke with phentermine.

Authors:  J Kokkinos; S R Levine
Journal:  Stroke       Date:  1993-02       Impact factor: 7.914

7.  Lacunar stroke associated with methylphenidate abuse.

Authors:  Hamid Sadeghian
Journal:  Can J Neurol Sci       Date:  2004-02       Impact factor: 2.104
  7 in total
  6 in total

1.  Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats.

Authors:  Felipe Schmitz; Emilene Barros da Silva Scherer; Maira Jaqueline da Cunha; Aline Andrea da Cunha; Daniela Delwing Lima; Débora Delwing; Carlos Alexandre Netto; Angela Terezinha de Souza Wyse
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

Review 2.  Advances in understanding and treating ADHD.

Authors:  Kevin M Antshel; Teresa M Hargrave; Mihai Simonescu; Prashant Kaul; Kaitlin Hendricks; Stephen V Faraone
Journal:  BMC Med       Date:  2011-06-10       Impact factor: 8.775

3.  Does the education system serve as a persuasion agent for recommending ADHD diagnosis and medication uptake? A qualitative case study to identify and characterize the persuasion strategies of Israeli teachers and school counselors.

Authors:  Anat Gesser-Edelsburg; Rasha Hamade Boukai
Journal:  BMC Psychiatry       Date:  2019-05-17       Impact factor: 3.630

4.  Digital Gangrene: An Unusual Manifestation of Non-Hodgkin Lymphoma.

Authors:  Muhammad Shoaib Momen Majumder; Shamim Ahmed; Tajkia Haque; Syed Atiqul Haq; Saumitra Chakravarty; Md Abu Shahin; Din-E-Mujahid Mohammad Faruque Osmany; Johannes J Rasker
Journal:  Case Rep Vasc Med       Date:  2022-03-02

Review 5.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09

6.  Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data.

Authors:  Susan M Hailpern; Brent M Egan; Kimberly D Lewis; Carol Wagner; Ghassan F Shattat; Doaa I Al Qaoud; Ibrahim F Shatat
Journal:  Front Pediatr       Date:  2014-09-19       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.